Synthetic Biology in Australia: An outlook to 2030

synbiology_cover-imageSynthetic biology involves the design and construction of new biological parts, devices, and systems, as well as the re-design of existing, natural biological systems for useful purposes. With early applications spanning across health care, climate change mitigation, biocontrol, agriculture and manufacturing the opportunities are significant. However, accompanying the high expectations of these technologies, there is considerable uncertainty and active debate on related social, cultural, ethical, health, economic, regulatory and legal issues.

This project will examine the opportunities and issues that synthetic biology will be likely to exert in Australia in the coming decade. 

The project is supported by CSIRO and the Department of Health.

Final report

The project report Synthetic Biology in Australia: an outlook to 2030, launched by Australia’s Chief Scientist, Dr Alan Finkel AO FAA FTSE at Customs House in Brisbane on 4 September 2018, is available here.

Expert Working Group

  • Professor Peter Gray AO FTSE (Chair)
  • Dr Sue Meek AO FTSE (Deputy Chair)
  • Professor Paul Griffiths FAHA
  • Professor Joseph Trapani FAHMS
  • Professor Ian Small FAA
  • Associate Professor Claudia Vickers
  • Professor Catherine Waldby FASSA

additional resources

Office of the Chief Scientist: Gene Editing and CRISPR